Results 151 to 160 of about 156,286 (266)
Outcomes of robotic repair for the degenerative mitral valve: a systematic review and meta-analysis. [PDF]
Eranki A +9 more
europepmc +1 more source
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun +23 more
wiley +1 more source
The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons. [PDF]
Gu H, Hu B, Jiang Y.
europepmc +1 more source
Application of Kaplan -Meier estimates to testing Cox power hypothesis for two progressive lycensored samples [PDF]
МГТУ им. Н.Э. Баумана +3 more
openalex +1 more source
IL‐15‐engineered stem cell–NK cell complexes, assembled via bioorthogonal chemistry, enable effective lung cancer immunotherapy. Abstract Natural killer (NK) cells represent a powerful immunotherapeutic strategy due to their intrinsic cytotoxicity and ability to target tumor cells independently of antigen presentation.
Qian Zhang +15 more
wiley +1 more source
Determining the threshold time in restricted mean survival time analysis for two group comparisons with applications in clinical and epidemiology studies. [PDF]
Han G +6 more
europepmc +1 more source
RNF213 is characterized as a dual‐functional antiviral effector. It directly mediates the degradation of the influenza A virus nucleoprotein (NP) while simultaneously activating the MDA5‐mediated innate immune signaling pathway. This coordinated response establishes a powerful host defense system against viral infection. ABSTRACT Influenza A virus (IAV)
Haoning Li +5 more
wiley +1 more source
A novel gene signature based on Like-Smith family members-related genes for predicting the prognosis of hepatocellular carcinoma. [PDF]
Chen S, Chen X, Sun X, Wu S.
europepmc +1 more source

